Progressive Supranuclear Palsy Clinical Trials

Find Progressive Supranuclear Palsy Clinical Trials Near You

Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study will compare health care utilisation and quality of life for patients with progressive supranuclear palsy, corticobasal syndrome and multiple system atrophy in different parts of the region that our specialist clinic operates in with different services as well as in other regions with no specialist clinics. This study aims to investigate which aspects of the service are most beneficial for the patients and to determine the influence of support services and specialty clinics on patients and their carers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Patients and their carers must:

• Be aged 18 or over

• Have capacity to consent at the beginning of their involvement

• Have a diagnosis of a neurodegenerative disease which includes progressive supranuclear palsy, corticobasal syndrome and multiple system atrophy but may include other closely related diseases where the presentation is similar, such as Alzheimer's disease where they present with a corticobasal syndrome

Locations
Other Locations
United Kingdom
Wessex Neurological Centre
RECRUITING
Southampton
Contact Information
Primary
Trial administrator Neurodegenerative research team
srikanth.anugu@uhs.nhs.uk
0044 2381206132
Time Frame
Start Date: 2022-10-10
Estimated Completion Date: 2027-07-15
Participants
Target number of participants: 198
Treatments
UHS Specialist Clinic population
All patients seen in regional clinic with this diagnosis
Interested patients from non-specialty clinics around the country.
Interested patients who meet the inclusion criteria and are from any region in the country with no movement disorder specialist clinic.
Sponsors
Leads: University Hospital Southampton NHS Foundation Trust

This content was sourced from clinicaltrials.gov